SCHEMBL4135470

SCHEMBL4135470

c1cnc(Sc2ncccn2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
HSP90AA1 P07900 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 2/20 0.36
KDM4E B2RXH2 2/20 0.36
EHMT2 Q96KQ7 1/20 0.36
EHMT1 Q9H9B1 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
MITF O75030 1/20 0.36
HTT P42858 1/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPK1 P28482 2/20 0.36
LMNA P02545 2/20 0.35
P4HTM Q9NXG6 2/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CCR1 P32246 1/20 0.35
CCR5 P51681 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10975798 0.81 HTT (0.33) HSD17B10SMN1; SMN2MAPTKDM4EMITF
SCHEMBL11198611 0.78 HSD17B10 (0.43) HSD17B10SMN1; SMN2MAPTKDM4EEHMT2
SCHEMBL192228 0.77 APOBEC3G (0.43) HSD17B10HDAC8HSP90AA1SMN1; SMN2MAPT
SCHEMBL17274043 0.77 POLB (0.52) SMN1; SMN2MAPTKDM4EAPOBEC3GHTT
SCHEMBL2129184 0.76 HSD17B10 (0.46) HSD17B10SMN1; SMN2MAPTKDM4EEHMT2
SCHEMBL12804177 0.74 EHMT2 (0.61) HSD17B10SMN1; SMN2MAPTKDM4EEHMT2
SCHEMBL1275151 0.73 KDM4E (0.36) HSD17B10HSP90AA1SMN1; SMN2MAPTKDM4E
SCHEMBL10396004 0.73 CYP3A4 (0.59) HSP90AA1MAPTKDM4EMAPK1CYP1A2
SCHEMBL7838204 0.72
SCHEMBL11319203 0.72 EHMT2 (0.39) HSD17B10HDAC8HSP90AA1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025103355-A1 ANTI-EGFR AND -HER3 BISPECIFIC ANTIBODY-DRUG CONJUGATE AND USE THEREOF 信达生物制药(苏州)有限公司 2025-05-22 WO claimed
WO-2025103355-A1 ANTI-EGFR AND -HER3 BISPECIFIC ANTIBODY-DRUG CONJUGATE AND USE THEREOF 信达生物制药(苏州)有限公司 2025-05-22 WO disclosed
CN-105218418-A A kind of preparation method of thioether UNIV YICHUN 2016-01-06 CN disclosed
US-8673885-B1 Compounds for the protection of sulfur containing linkers in nucleic acid synthesis DUFF ROBERT (US) 2014-03-18 US disclosed
US-20090061460-A1 TEST APPARATUS, PRODUCTION METHOD THEREFOR AND TEST METHOD ANALYTICON BIOTECHNOLOGIES AG (DE) 2009-03-05 US disclosed
EP-0124630-B1 PYRIMIDINETHIOALKYL PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS LUDWIG HEUMANN & CO GMBH (DE) 1987-01-28 EP disclosed